Predictors of mortality in beta-hemolytic streptococcal bacteremia: A population-based study

Journal of Infection

Volumn 58, Issue 4, 2009, Pages 266-272

  Rantala, Sari ^a   Vuopio Varkila, Jaana ^b   Vuento, Risto ^a   Huhtala, Heini ^c   Syrjänen, Jaana ^a,d  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c UNIVERSITY OF TAMPERE   (Finland)

^d TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

Author keywords

Bacteremia; Beta hemolytic; Cellulitis; Clinical characteristics; Mortality; Streptococci

Indexed keywords

ADOLESCENT; ADULT; ALCOHOLISM; ARTICLE; BLOOD CULTURE; CELLULITIS; CONFUSION; DISEASE SURVEILLANCE; DYSPNEA; FEMALE; FEVER; FINLAND; GROUP A STREPTOCOCCAL INFECTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NECROTIZING FASCIITIS; POPULATION RESEARCH; PROGNOSIS; RETROSPECTIVE STUDY; SKIN INFECTION; SOFT TISSUE INFECTION; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS GROUP A; STREPTOCOCCUS GROUP C; STREPTOCOCCUS GROUP G; UNCONSCIOUSNESS;

BACTEREMIA; FEMALE; HUMANS; MALE; MULTIVARIATE ANALYSIS; POPULATION SURVEILLANCE; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; STATISTICS, NONPARAMETRIC; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS;

EID: 63149158536     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2009.01.015     Document Type: Article

References (34)

1. Davies H.D., McGeer A., Schwartz B., Green K., Cann D., Simor A.E., et al. Invasive group A streptococcal infections in Ontario, Canada. Ontario group A streptococcal study group. N Engl J Med 335 (1996) 547-554
2. Stevens D.L. Invasive group A streptococcus infections. Clin Infect Dis 14 (1992) 2-11
3. Thigpen M.C., Richards Jr. C.L., Lynfield R., Barrett N.L., Harrison L.H., Arnold K.E., et al. Invasive group A streptococcal infection in older adults in long-term care facilities and the community, United States, 1998-2003. Emerging Infect Dis 13 (2007) 1852-1859
4. O'Loughlin R.E., Roberson A., Cieslak P.R., Lynfield R., Gershman K., Craig A., et al. The epidemiology of invasive group A streptococcal infection and potential vaccine implications: United States, 2000-2004. Clin Infect Dis 45 (2007) 853-862
5. O'Brien K.L., Beall B., Barrett N.L., Cieslak P.R., Reingold A., Farley M.M., et al. Epidemiology of invasive group a streptococcus disease in the United States, 1995-1999. Clin Infect Dis 35 (2002) 268-276
6. Mehta S., McGeer A., Low D.E., Hallett D., Bowman D.J., Grossman S.L., et al. Morbidity and mortality of patients with invasive group A streptococcal infections admitted to the ICU. Chest 130 (2006) 1679-1686
7. Hollm-Delgado M.G., Allard R., and Pilon P.A. Invasive group A streptococcal infections, clinical manifestations and their predictors, Montreal, 1995-2001. Emerging Infect Dis 11 (2005) 77-82
8. Ekelund K., Skinhoj P., Madsen J., and Konradsen H.B. Invasive group A, B, C and G streptococcal infections in Denmark 1999-2002: epidemiological and clinical aspects. Clin Microbiol Infect 11 (2005) 569-576
9. Sharkawy A., Low D.E., Saginur R., Gregson D., Schwartz B., Jessamine P., et al. Severe group a streptococcal soft-tissue infections in Ontario: 1992-1996. Clin Infect Dis 34 (2002) 454-460
10. Nielsen S.V., and Kolmos H.J. Bacteraemia due to different groups of beta-haemolytic streptococci: a two-year survey and presentation of a case of recurring infection due to Streptococcus "equisimilis". Infection 21 (1993) 358-361
11. Stevens D.L. Could nonsteroidal antiinflammatory drugs (NSAIDs) enhance the progression of bacterial infections to toxic shock syndrome?. Clin Infect Dis 21 (1995) 977-980
12. Stevens D.L. The toxic shock syndromes. Infect Dis Clin North Am 10 (1996) 727-746
13. McCabe W.R., and Jacson G.G. Gram-negative bacteremia. II. Clinical, laboratory, and therapeutic observations. Arch Intern Med 110 (1962) 856-864
14. Defining the group A streptococcal toxic shock syndrome. Rationale and consensus definition. The working group on severe streptococcal infections. JAMA 269 (1993) 390-391
15. Kuusi M., Lahti E., Virolainen A., Hatakka M., Vuento R., Rantala L., et al. An outbreak of Streptococcus equi subspecies zooepidemicus associated with consumption of fresh goat cheese. BMC Infect Dis 6 (2006) 36
16. Weinstein M.P., Murphy J.R., Reller L.B., and Lichtenstein K.A. The clinical significance of positive blood cultures: a comprehensive analysis of 500 episodes of bacteremia and fungemia in adults. II. Clinical observations, with special reference to factors influencing prognosis. Rev Infect Dis 5 (1983) 54-70
17. Pittet D., Thievent B., Wenzel R.P., Li N., Auckenthaler R., and Suter P.M. Bedside prediction of mortality from bacteremic sepsis. A dynamic analysis of ICU patients. Am J Respir Crit Care Med 153 (1996) 684-693
18. Darenberg J., Luca-Harari B., Jasir A., Sandgren A., Pettersson H., Schalen C., et al. Molecular and clinical characteristics of invasive group A streptococcal infection in Sweden. Clin Infect Dis 45 (2007) 450-458
19. Tyrrell G.J., Senzilet L.D., Spika J.S., Kertesz D.A., Alagaratnam M., Lovgren M., et al. Invasive disease due to group B streptococcal infection in adults: results from a Canadian, population-based, active laboratory surveillance study-1996. Sentinel health unit surveillance system site coordinators. J Infect Dis 182 (2000) 168-173
20. Farley M.M. Group B streptococcal disease in nonpregnant adults. Clin Infect Dis 33 (2001) 556-561
21. Edwards M.S., and Baker C.J. Group B streptococcal infections in elderly adults. Clin Infect Dis 41 (2005) 839-847
22. Auckenthaler R., Hermans P.E., and Washington II J.A. Group G streptococcal bacteremia: clinical study and review of the literature. Rev Infect Dis 5 (1983) 196-204
23. Cohen-Poradosu R., Jaffe J., Lavi D., Grisariu-Greenzaid S., Nir-Paz R., Valinsky L., et al. Group G streptococcal bacteremia in Jerusalem. Emerging Infect Dis 10 (2004) 1455-1460
24. Lewthwaite P., Parsons H.K., Bates C.J., McKendrick M.W., and Dockrell D.H. Group G streptococcal bacteraemia: an opportunistic infection associated with immune senescence. Scand J Infect Dis 34 (2002) 83-87
25. Lamagni T.L., Darenberg J., Luca-Harari B., Siljander T., Efstratiou A., Henriques-Normark B., et al. Epidemiology of severe Streptococcus pyogenes disease in Europe. J Clin Microbiol 46 (2008) 2359-2367
26. Stevens D.L. Streptococcal toxic-shock syndrome: spectrum of disease, pathogenesis, and new concepts in treatment. Emerging Infect Dis 1 (1995) 69-78
27. Lamagni T.L., Neal S., Keshishian C., Alhaddad N., George R., Duckworth G., et al. Severe Streptococcus pyogenes infections, United Kingdom, 2003-2004. Emerging Infect Dis 14 (2008) 202-209
28. Schlievert P.M., Gocke J.E., and Deringer J.R. Group B streptococcal toxic shock-like syndrome: report of a case and purification of an associated pyrogenic toxin. Clin Infect Dis 17 (1993) 26-31
29. Natoli S., Fimiani C., Faglieri N., Laurenzi L., Calamaro A., Frasca A.M., et al. Toxic shock syndrome due to group C streptococci. A case report. Intensive Care Med 22 (1996) 985-989
30. Jankowski S., MacLachlan K., Stephenson J., and Thomas P. Necrotising infections and group G streptococcus. Lancet 359 (2002) 2277
31. Tang W.M., Ho P.L., Yau W.P., Wong J.W., and Yip D.K. Report of 2 fatal cases of adult necrotizing fasciitis and toxic shock syndrome caused by Streptococcus agalactiae. Clin Infect Dis 31 (2000) E15-E17
32. Thomas S., and Cunha B.A. Group B streptococcal toxic shock-like syndrome with fulminant cellulitis. Heart Lung 25 (1996) 497-499
33. Bernaldo de Quiros J.C., Moreno S., Cercenado E., Diaz D., Berenguer J., Miralles P., et al. Group A streptococcal bacteremia. A 10-year prospective study. Medicine (Baltimore) 76 (1997) 238-248
34. Mitaka C. Clinical laboratory differentiation of infectious versus non-infectious systemic inflammatory response syndrome. Clin Chim Acta 351 (2005) 17-29